Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price57.83 USD
Fair value46.10
Ethical score88.7/100
RatingOVERVALUED
Our investment reviews on this name
2026-10-02Read Distribution57.83+0.0% to today
2026-08-23Read Markup62.78-7.9% to today
2026-07-02Read Markdown62.59-7.6% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Baker Hughes holds its Markdown at $57.83. The statistical read favours the sellers, held for 6 days.
As held on the ledger · 2026-09-25
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 6 days
Price at the screen
$57.83
Valuation
18.59 trailing · 18.59 forward price to earnings
Values screen
PASS· score 88.7
Beta
0.96
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
14.89%
Below 33%
Interest-bearing debt is just 14.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
22.68%
Below 49%
Money owed to the company is 22.7% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Baker Hughes clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 15%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OVERVALUED: it trades above our $46.10 fair value estimate, moderate competitive moat.
Fair value range in USD, drawn from the 2026-09-25 screen. The gold marker is the market price at the same screen. The price runs 20.3% above the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +28% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-25 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Oil kit priced above the cycle peak
Baker Hughes sells the pumps, sensors and crews that keep oil and gas flowing when prices rise. Right now the shares sit at $55.95, twenty percent above our fair value of $44.51, even though revenue is growing only two percent and margins sit at eleven percent.
A forward multiple of 19.7 times earnings looks rich for a moderate-moat business in a sector that rises and falls with commodity prices. The seventeen percent return on equity may look solid today, yet in cyclical industries that figure often marks the top of the cycle rather than a floor.
When activity slows the earnings that justify the current price can drop fast, turning what appears steady into a value trap. The ethical screen clears, but the numbers do not. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BKR trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72.
2026-08-23Markup · changed$62.78+12.2%Entry 5
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72.
2026-07-23Markdown$55.95-10.6%Entry 4
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 10.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72.
2026-07-18Markdown$62.59+0.0%Entry 3
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 65%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $72.
2026-07-03Markdown$62.59+0.0%Entry 2
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markdown$62.59Entry 1
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
